Clinical Relevance of Lepidoglyphus destructor Sensitisation in Allergic Rhinitis: Nasal Provocation Test as in vivo Assessment.

Autor: Matos Semedo F; Department of Immunoallergy, Hospital da Luz Lisboa, Lisbon, Portugal, pipa.semedo@gmail.com.; Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal, pipa.semedo@gmail.com.; NOVA Medical School, Nova University of Lisbon, Lisbon, Portugal, pipa.semedo@gmail.com., Martins C; NOVA Medical School, Nova University of Lisbon, Lisbon, Portugal.; Comprehensive Health Research Centre (CHRC), NOVA Medical School, Nova University of Lisbon, Lisbon, Portugal., Tomaz E; Department of Immunoallergology, Hospital de São Bernardo, Centro Hospitalar de Setúbal, Setúbal, Portugal., Cardoso B; Department of Immunoallergy, Hospital CUF Descobertas, Lisbon, Portugal., Farinha S; Department of Immunoallergology, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal., Martins M; Department of Immunoallergy, Hospital CUF Descobertas, Lisbon, Portugal., Paula Pires A; Department of Immunoallergology, Hospital de São Bernardo, Centro Hospitalar de Setúbal, Setúbal, Portugal., Inácio F; Department of Immunoallergology, Hospital de São Bernardo, Centro Hospitalar de Setúbal, Setúbal, Portugal., Taborda-Barata L; CICS- Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.; UBIAir - Clinical and Experimental Lung Centre, University of Beira Interior, Covilhã, Portugal.; Department of Allergy and Clinical Immunology, Cova da Beira University Hospital Centre, Covilhã, Portugal.

Publikováno v: International archives of allergy and immunology [Int Arch Allergy Immunol] 2024; Vol. 185 (5), pp. 436-448. Date of Electronic Publication: 2024 Jan 24.

Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis.

Autor: Eguiluz-Gracia I; Allergy Unit, IBIMA-Hospital Regional Universitario de Málaga-ARADyAL, UMA, Málaga, Spain., Parkin RV; National Heart and Lung Institute, Imperial College London, London, UK.; The MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK., Layhadi JA; National Heart and Lung Institute, Imperial College London, London, UK.; The MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK., Palmer E; National Heart and Lung Institute, Imperial College London, London, UK.; The MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK., Meng X; National Heart and Lung Institute, Imperial College London, London, UK.; The MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK., Zhu R; National Heart and Lung Institute, Imperial College London, London, UK.; The MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK., Sahiner U; National Heart and Lung Institute, Imperial College London, London, UK.; The MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK., Durham SR; National Heart and Lung Institute, Imperial College London, London, UK.; The MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK., Torres MJ; Allergy Unit, IBIMA-Hospital Regional Universitario de Málaga-ARADyAL, UMA, Málaga, Spain., Mayorga C; Allergy Unit, IBIMA-Hospital Regional Universitario de Málaga-ARADyAL, UMA, Málaga, Spain., Rondon C; Allergy Unit, IBIMA-Hospital Regional Universitario de Málaga-ARADyAL, UMA, Málaga, Spain., Shamji MH; National Heart and Lung Institute, Imperial College London, London, UK.; The MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK.

Publikováno v: Allergy [Allergy] 2024 Aug; Vol. 79 (8), pp. 2197-2206. Date of Electronic Publication: 2024 Mar 14.

Clinical validation of grass pollen exposure chamber in patients with allergic rhinitis triggered by timothy grass.

Autor: Kosowska A; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.; ALL-MED Medical Research Institute, Wroclaw, Poland., Zemelka-Wiącek M; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland., Smolińska S; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland., Wyrodek E; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland., Adamczak B; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland., Jutel M; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.; ALL-MED Medical Research Institute, Wroclaw, Poland.

Publikováno v: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2024 Jul; Vol. 54 (7), pp. 489-499. Date of Electronic Publication: 2024 Apr 14.

Nasal hyperreactivity in allergic rhinitis and chronic rhinosinusitis with polyps: a role for neuronal pathways.

Autor: Backaert W; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium; University Hospitals Leuven, Department of Otorhinolaryngology, Head and Neck surgery, Leuven, Belgium., Steelant B; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium., Wils T; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium., Qian Z; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium., Dilissen E; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium., Jonckheere AC; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium., Boonen B; KU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Ion Channel Research, Leuven, Belgium; VIB, Center for Brain and Disease Research, Leuven, Belgium., Jorissen M; University Hospitals Leuven, Department of Otorhinolaryngology, Head and Neck surgery, Leuven, Belgium; KU Leuven, Department of Neurosciences, Experimental Otorhinolaryngology, Leuven, Belgium., Schrijvers R; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium; KU Leuven, Department of Microbiology, Immunology and Transplantation, Laboratory of Adaptive Immunology, Leuven, Belgium; University Hospitals Leuven, Department of General Internal Medicine, Leuven, Belgium., Bullens DMA; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium; University Hospitals Leuven, Department of Paediatrics, Leuven, Belgium., Talavera K; KU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Ion Channel Research, Leuven, Belgium; VIB, Center for Brain and Disease Research, Leuven, Belgium., Hellings PW; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium; University Hospitals Leuven, Department of Otorhinolaryngology, Head and Neck surgery, Leuven, Belgium;U Ghent, Department of Otorhinolaryngology, Laboratory of Upper Airways Research, Ghent, Belgium;Academic Medical Center, Department of Otorhinolaryngology, Amsterdam, The Netherlands., Van Gerven L; KU Leuven, Department of Microbiology, Immunology and Transplantation, Allergy and Clinical Immunology Research Group, Leuven, Belgium; University Hospitals Leuven, Department of Otorhinolaryngology, Head and Neck surgery, Leuven, Belgium;KU Leuven, Department of Neurosciences, Experimental Otorhinolaryngology, Leuven, Belgium.

Publikováno v: Rhinology [Rhinology] 2024 Jun 01; Vol. 62 (3), pp. 299-309.

Nasal IL-13 production identifies patients with late-phase allergic responses.

Autor: Campion NJ; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria., Villazala-Merino S; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria., Thwaites RS; National Heart and Lung Institute, Imperial College of London, London, United Kingdom., Stanek V; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria., Killick H; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Pertsinidou E; Research and Development, Thermo Fisher Scientific, Uppsala, Sweden., Zghaebi M; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria., Toth J; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria., Fröschl R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Perkmann T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Gangl K; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria., Schneider S; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria., Ristl R; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria., Scott IC; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Cohen ES; Bioscience Asthma, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Molin M; Research and Development, Thermo Fisher Scientific, Uppsala, Sweden., Focke-Tejkl M; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria; Karl Landsteiner University of Health Sciences, Krems, Austria., Regelsberger G; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria., Hansel TT; National Heart and Lung Institute, Imperial College of London, London, United Kingdom., Valenta R; Division of Immunopathology, Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria; Karl Landsteiner University of Health Sciences, Krems, Austria., Niederberger-Leppin V; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria. Electronic address: verena.niederberger@meduniwien.ac.at., Eckl-Dorna J; Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2023 Nov; Vol. 152 (5), pp. 1167-1178.e12. Date of Electronic Publication: 2023 Aug 01.